The TF, Forkhead Box A2 (FOXA2) was discovered to have high expression in NEPC cell lines and PDX models compared to being absent or low-expressed in prostate adenocarcinoma, with its expression promoted by ADT [106,107]. Here, FOXA2 is linked to prostate adenocarcinoma.